122 related articles for article (PubMed ID: 38479278)
1. TGFβ signaling pathway in salivary gland tumors.
Gomes ÁNM; Oliveira KK; Marchi FA; Bettim BB; Germano JN; Gonçalves Filho J; Pinto CAL; Lourenço SV; Coutinho-Camillo CM
Arch Oral Biol; 2024 Jun; 162():105943. PubMed ID: 38479278
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
3. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
4. Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin.
Prabhu S; Kaveri H; Rekha K
Oral Oncol; 2009 Jul; 45(7):594-9. PubMed ID: 18955011
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
8. Expression of ras-P21 in salivary gland tumors.
Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
[No Abstract] [Full Text] [Related]
9. Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors.
Tenório JDR; da Silva LP; Xavier MGA; Santana T; do Nascimento GJF; Sobral APV
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2341-2347. PubMed ID: 30003391
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
11. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like Growth Factor II Messenger RNA-binding Protein 3 in Salivary Gland Tumors.
Ismerim AB; Ferreira SV; Lessa AM; Pereira Júnior AS; Gurgel CA; Coutinho-Camillo CM; Soares FA; Vilas-Bôas DS; Vidal MT; Santos JN
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):422-6. PubMed ID: 26258757
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of the expression of human chorionic gonadotropin-β in salivary gland tumors.
Meda S; Reginald BA; Reddy BS
J Cancer Res Ther; 2018; 14(5):952-956. PubMed ID: 30197330
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
[TBL] [Abstract][Full Text] [Related]
15. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
[TBL] [Abstract][Full Text] [Related]
17. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 13 expression in salivary gland tumors.
Darling MR; Jackson-Boeters L; Daley TD; Diamandis EP
Int J Biol Markers; 2006; 21(2):106-10. PubMed ID: 16847813
[TBL] [Abstract][Full Text] [Related]
20. Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma.
Branco KFCC; Ribeiro ALR; de Mendonça RP; de Jesus Viana Pinheiro J; da Silva Kataoka MS; Arnaud MVC; de Melo Alves Junior S
Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3039-3047. PubMed ID: 30367261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
